I made a mistake in my post by mentioning only cost. Any company, large or small, using an inadequate or inferior product would be a target. It may have been cost, a poor choice, or simply the best that was available at the time. However I still feel that massive, global companies such as the ones you mention are possible future adopters rather than initial targets.
- Forums
- ASX - By Stock
- HHI
- Ann: New SME Pricing
Ann: New SME Pricing, page-50
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HHI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online